BACKGROUND AND PURPOSE:Neurocognitive decline occurs frequently after cardiac surgery and persists in a significant number of patients. Magnesium is thought to provide neuroprotection by preservation of cellular energy metabolism, blockade of the N-methyl-D-aspartate receptor, diminution of the inflammatory response, and inhibition of platelet activation. We therefore hypothesized that intraoperative magnesium administration would decrease postoperative cognitive impairment. METHODS: After approval by the Duke University Health System Institutional Review Board, 389 patients undergoing cardiac surgery were enrolled in this prospective, randomized, double-blind, placebo-controlled clinical trial. Subjects were randomized to receive magnesium as a 50 mg/kg bolus followed by another 50 mg/kg infusion for 3 hours or placebo bolus and infusion. Cognitive function was assessed preoperatively and again at 6 weeks postoperatively using a standardized test battery. MeanCD11b fluorescence and percentage of platelets expressing CD62P, which are markers of leukocyte and platelet activation, respectively, were assessed by flow cytometry as a secondary outcome. The effect of magnesium on postoperative cognition was tested using multivariable regression modeling, adjusting for age, years of education, baseline cognition, sex, race, and weight. RESULTS: Among the 389 allocated subjects (magnesium: n=198; placebo: n=191), the incidence of cognitive deficit in the magnesium group was 44.4% compared with 44.9% in the placebo group (P=0.93). The cognitive change score and platelet and leukocyte activation were also not different between the groups. Multivariable analysis revealed a marginal interaction between treatment group and weight such that heavier subjects receiving magnesium were less likely to have cognitive deficit (P=0.06). CONCLUSIONS:Magnesium administered intravenously during cardiac surgery does not reduce postoperative cognitive dysfunction. CLINICAL TRIAL REGISTRATION URL: http://www.clinicaltrials.gov. Unique identifier: NCT00041392.
RCT Entities:
BACKGROUND AND PURPOSE: Neurocognitive decline occurs frequently after cardiac surgery and persists in a significant number of patients. Magnesium is thought to provide neuroprotection by preservation of cellular energy metabolism, blockade of the N-methyl-D-aspartate receptor, diminution of the inflammatory response, and inhibition of platelet activation. We therefore hypothesized that intraoperative magnesium administration would decrease postoperative cognitive impairment. METHODS: After approval by the Duke University Health System Institutional Review Board, 389 patients undergoing cardiac surgery were enrolled in this prospective, randomized, double-blind, placebo-controlled clinical trial. Subjects were randomized to receive magnesium as a 50 mg/kg bolus followed by another 50 mg/kg infusion for 3 hours or placebo bolus and infusion. Cognitive function was assessed preoperatively and again at 6 weeks postoperatively using a standardized test battery. Mean CD11b fluorescence and percentage of platelets expressing CD62P, which are markers of leukocyte and platelet activation, respectively, were assessed by flow cytometry as a secondary outcome. The effect of magnesium on postoperative cognition was tested using multivariable regression modeling, adjusting for age, years of education, baseline cognition, sex, race, and weight. RESULTS: Among the 389 allocated subjects (magnesium: n=198; placebo: n=191), the incidence of cognitive deficit in the magnesium group was 44.4% compared with 44.9% in the placebo group (P=0.93). The cognitive change score and platelet and leukocyte activation were also not different between the groups. Multivariable analysis revealed a marginal interaction between treatment group and weight such that heavier subjects receiving magnesium were less likely to have cognitive deficit (P=0.06). CONCLUSIONS:Magnesium administered intravenously during cardiac surgery does not reduce postoperative cognitive dysfunction. CLINICAL TRIAL REGISTRATION URL: http://www.clinicaltrials.gov. Unique identifier: NCT00041392.
Authors: M F Newman; J L Kirchner; B Phillips-Bute; V Gaver; H Grocott; R H Jones; D B Mark; J G Reves; J A Blumenthal Journal: N Engl J Med Date: 2001-02-08 Impact factor: 91.245
Authors: Barbara Phillips-Bute; Joseph P Mathew; James A Blumenthal; Hilary P Grocott; Daniel T Laskowitz; Robert H Jones; Daniel B Mark; Mark F Newman Journal: Psychosom Med Date: 2006 May-Jun Impact factor: 4.312
Authors: Nancy R Temkin; Gail D Anderson; H Richard Winn; Richard G Ellenbogen; Gavin W Britz; James Schuster; Timothy Lucas; David W Newell; Pamela Nelson Mansfield; Joan E Machamer; Jason Barber; Sureyya S Dikmen Journal: Lancet Neurol Date: 2007-01 Impact factor: 44.182
Authors: George Djaiani; Ludwik Fedorko; Michael A Borger; Robin Green; Jo Carroll; Michael Marcon; Jacek Karski Journal: Circulation Date: 2007-10-08 Impact factor: 29.690
Authors: Joseph P Mathew; G Burkhard Mackensen; Barbara Phillips-Bute; Hilary P Grocott; Donald D Glower; Daniel T Laskowitz; James A Blumenthal; Mark F Newman Journal: Stroke Date: 2009-01-22 Impact factor: 7.914
Authors: William J Mack; Christopher P Kellner; Daniel H Sahlein; Andrew F Ducruet; Grace H Kim; J Mocco; Joseph Zurica; Ricardo J Komotar; Raqeeb Haque; Robert Sciacca; Donald O Quest; Robert A Solomon; E Sander Connolly; Eric J Heyer Journal: J Neurosurg Date: 2009-05 Impact factor: 5.115
Authors: Miles Berger; Jacob W Nadler; Jeffrey Browndyke; Niccolo Terrando; Vikram Ponnusamy; Harvey Jay Cohen; Heather E Whitson; Joseph P Mathew Journal: Anesthesiol Clin Date: 2015-07-16
Authors: Miles Berger; Deborah Oyeyemi; Mobolaji O Olurinde; Heather E Whitson; Kent J Weinhold; Marty G Woldorff; Lewis A Lipsitz; Eugene Moretti; Charles M Giattino; Kenneth C Roberts; Junhong Zhou; Thomas Bunning; Michael Ferrandino; Randall P Scheri; Mary Cooter; Cliburn Chan; Roberto Cabeza; Jeffrey N Browndyke; David M Murdoch; Michael J Devinney; Leslie M Shaw; Harvey Jay Cohen; Joseph P Mathew Journal: J Am Geriatr Soc Date: 2019-01-23 Impact factor: 5.562
Authors: Karsten Bartels; Yi-Ju Li; Yen-Wei Li; William D White; Daniel T Laskowitz; Miklos D Kertai; Mark Stafford-Smith; Mihai V Podgoreanu; Mark F Newman; Joseph P Mathew Journal: Can J Anaesth Date: 2015-03-06 Impact factor: 5.063
Authors: Jeffrey N Browndyke; Miles Berger; Patrick J Smith; Todd B Harshbarger; Zachary A Monge; Viral Panchal; Tiffany L Bisanar; Donald D Glower; John H Alexander; Roberto Cabeza; Kathleen Welsh-Bohmer; Mark F Newman; Joseph P Mathew Journal: Hum Brain Mapp Date: 2017-11-21 Impact factor: 5.038
Authors: Miles Berger; Niccolò Terrando; S Kendall Smith; Jeffrey N Browndyke; Mark F Newman; Joseph P Mathew Journal: Anesthesiology Date: 2018-10 Impact factor: 7.892